The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.

The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe ...

Canada’s UHN and U of T researchers have created a skin-based test that identifies progressive supranuclear palsy (PSP) ...

HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing ...

GE HealthCare is expecting its 2025 revenues to take a hit of around $500m due to the Trump administration’s imposition of ...

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...

CAD and Microsoft to incorporate a suite of AI-powered mammography solutions into ProFound Breast Health Suite on the ...

US-based medical device technology company HemoSonics has won the Marketing award in the 2025 Medical Device Network ...

Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.

A baby has been born following an AI-automated in vitro fertilisation (IVF) procedure conducted remotely by engineers and ...

The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain ...